Estrogen Receptor Negative
Showing 1 - 25 of 43
Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Edema
- +8 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2023
Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,
Active, not recruiting
- Estrogen Receptor Negative
- +11 more
- Capecitabine
- +2 more
-
Mobile, Alabama
- +1023 more
Dec 7, 2022
Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Active, not recruiting
- Anatomic Stage IIB Breast Cancer AJCC v8
- +19 more
-
Gilbert, Arizona
- +4 more
Dec 6, 2022
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,
Active, not recruiting
- Estrogen Receptor Negative
- +15 more
- Cyclophosphamide
- +6 more
-
Bellevue, Nebraska
- +3 more
Nov 30, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Suspended
- Anatomic Stage 0 Breast Cancer AJCC v8
- +18 more
- Celecoxib
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 4, 2022
Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)
Active, not recruiting
- Triple -Negative Breast Cancer
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 1, 2022
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative Trial in Duarte, Rancho Cucamonga, South Pasadena
Completed
- Estrogen Receptor Negative
- +4 more
- everolimus
- +3 more
-
Duarte, California
- +2 more
Jun 6, 2022
BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic
Recruiting
- BARD1 Gene Mutation
- +14 more
- Educational Intervention
- +3 more
-
Houston, Texas
- +1 more
Jun 14, 2022
Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)
Active, not recruiting
- Androgen Receptor Positive
- +5 more
- Enobosarm
- +2 more
-
Corona, California
- +6 more
Jun 8, 2022
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,
Active, not recruiting
- Estrogen Receptor Negative
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Houston, Texas
- +5 more
Feb 11, 2022
Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,
Active, not recruiting
- Estrogen Receptor Negative
- +6 more
- Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +8 more
Feb 3, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage IA Breast Cancer AJCC v8
- +27 more
- Aspiration of Breast
- Biospecimen Collection
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 29, 2021
Collecting, Analyzing, and Storing Samples From Metastatic,
Terminated
- Estrogen Receptor Negative
- +4 more
- Cytology Specimen Collection Procedure
- +3 more
-
Seattle, Washington
- +1 more
Sep 23, 2021
Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation
Recruiting
- Estrogen Receptor Negative
- +11 more
- External Beam Radiation Therapy
- +4 more
-
Phoenix, Arizona
- +7 more
Aug 4, 2021
Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,
Active, not recruiting
- Inflammatory Breast Cancer
- +9 more
- carboplatin
- +2 more
-
Duarte, California
- +1 more
Jul 9, 2021
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8
Completed
- Anatomic Stage II Breast Cancer AJCC v8
- +20 more
- Mirvetuximab Soravtansine
-
Houston, TexasM D Anderson Cancer Center
Nov 18, 2020
Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in
Completed
- Advanced Malignant Solid Neoplasm
- +24 more
- Oxidative Phosphorylation Inhibitor IACS-010759
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative Trial in Portland (Durvalumab, Olaparib)
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Durvalumab
- Olaparib
-
Portland, OregonOHSU Knight Cancer Institute
Nov 18, 2020
Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,
Unknown status
- Estrogen Receptor Negative
- +9 more
- Capecitabine
- +2 more
-
Chicago, Illinois
- +1 more
Jun 25, 2020
Breast Carcinoma Metastatic in the Brain, Estrogen Receptor Negative, HER2/Neu Negative Trial in Chicago, Lake Forest, Houston
Terminated
- Breast Carcinoma Metastatic in the Brain
- +6 more
- Cognitive Assessment
- +3 more
-
Chicago, Illinois
- +2 more
Apr 2, 2020
Ductal Breast Carcinoma, Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative Trial in Buffalo (Broccoli Sprout Extract,
Completed
- Ductal Breast Carcinoma
- +10 more
- Broccoli Sprout Extract
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 29, 2019
Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Akt Inhibitor GSK2141795,
Completed
- Estrogen Receptor Negative
- +6 more
- Akt Inhibitor GSK2141795
- +2 more
-
Washington, District of Columbia
- +7 more
Aug 27, 2019